H.I.G. Capital Acquires Morningside Healthcare and Morningside Pharmaceuticals
H.I.G. Capital, and its portfolio company Aspire Pharma, acquired Morningside Healthcare and Morningside Pharmaceuticals, a UK provider of niche generic and branded specialty pharmaceuticals.
October 4, 2022
Aspire Pharma | Citigroup Global Markets | Eversheds Sutherland (International) | H.I.G. Capital | Jefferies International Limited | Kirkland & Ellis International | Morningside Healthcare | Morningside Pharmaceuticals | Richard Condon | Rohin Jain
Ian Koplin